Comprehensive Library Of Research Reports

Holistic Analysis Customized Solutions Top Quality

Get The Free Sample Complete
SWOT & PESTLE Analysis Report
This report is shared in order to give you an idea of what the complete SWOT & PESTLE analysis report will cover after purchase.
Get this sample report, completely free
DOWNLOAD NOW
In case you want this report emailed straight into your email inbox, kindly share your details below. Please note that you agree to receive email updates from us on our new reports and solutions.
No, Thanks
Get Your Free Summary Copy of the
SWOT & PESTLE Analysis Report
The Summary report contains the SWOT & PESTLE table contents only. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this free summary report
DOWNLOAD REPORT
In case you want this report emailed straight into your email inbox, kindly share your details below. Please note that you agree to receive email updates from us on our new reports and solutions.
No Thanks

Hikma Pharmaceuticals plc SWOT and PESTLE Analysis

ID : 521070753| May 2023| 19 pages

COMPANY PROFILE -Hikma Pharmaceuticals plc

Business Sector :Pharmaceuticals

Operating Geography :United Kingdom, Europe, Global

About Hikma Pharmaceuticals plc :

Hikma Pharmaceuticals plc is a non-branded generic and in-licensed pharmaceutical company headquartered in London, United Kingdom. In 1978, Samih Darwazah founded the company in Amman, Jordan. The company has 29 manufacturing facilities spread across 11 countries: the United States, Portugal, Italy, Jordan, Saudi Arabia, Algeria, Germany, Egypt, Morocco, Tunisia, and Sudan. It undertakes research and development in the areas such as cardiology, anti-infective, neurology, and dermatology. In the MENA region, Hikma's branded business segment consists of the development and sale of branded generics and in-licensed patented products. It offers 499 different medications in 1,256 different dosage strengths. Actos, Amoclan, Blopress, Omnicef, Prograf, and Suprax are some of the most popular products. Argatroban, fentanyl, phenylephrine, Robaxin, and iron gluconate are among the speciality injectable medications sold by Hikma in the United States, Europe, and MENA. As of early 2023, Hikma employed over 8,700 people.

Hikma Pharmaceutical's USP lies in its reputation for quality, high brand awareness, and FDA-inspected manufacturing facilities in the United States. The mission statement of Hikma Pharmaceuticals reads, "Improving lives' is Hikma's main mission, through providing high-quality affordable medication to patients and 'Improving lives' of its local communities and its employees".

Hikma Pharmaceuticals plc Revenue :


US$ 2,553 million - FY ending 31st December 2021
US$ 2,341 million - FY ending 31st December 2020

Competitive Analysis of Hikma Pharmaceuticals plc

SWOT
PESTLE
The SWOT analysis for Hikma Pharmaceuticals plc is presented below in a matrix followed by the detailed analysis report:
StrengthsWeaknesses
1. Strongly positioned to deliver sustainable growth
2. World-class infrastructure for generics development and manufacturing
3. Manufacturing flexibility can handle fluctuating demand
4. Continuous launch of new drugs
5. One of the largest pharmaceutical brands in MENA
6. Consistently maintained cash flow that supports R&D
1. Presence in few products categories
OpportunitiesThreats
1. High demand for Covid-19 treatment drugs
2. Elective surgery products will see demand post covid
3. Biosimilar received a positive response in US
1. Emerging innovative sales channels increase competition
2. Reduced supply of APIs is inhibiting production
3. Patent infringement litigation with Amarin pharma
Sample Complete Report
This is the sample complete report which will give you a glimpse of what your complete report will cover after purchase.
Free Summary Report
This report contains the table contents only. In case you need the complete report please purchase using the buy options displayed.
* By clicking on "Buy Now" you agree to accept our "Terms and Conditions."
SWOT & PESTLE (combined)
Complete Report
USD 27
*
  • Debit/Credit card
  • PayPal
Great quality, Affordable pricing.
Safe and secure payments
Hikma Pharmaceuticals plc SWOT and PESTLE Analysis PDF Report is a custom report and will be delivered to your email inbox within 2 business days from purchase.

Detailed SWOT Analysis of Hikma Pharmaceuticals plc

Strength

This section is available only in the 'Complete Report' on purchase.

Weakness

This section is available only in the 'Complete Report' on purchase.

Opportunity

1. High demand for Covid-19 treatment drugs: Pharmaceuticals industry saw a tectonic shift in demand towards drugs used for treatment of Covid-19 induced symptoms. Drugs such as Hydroxychloroquine, Ivermectin and Favipiravir were in massive demand across the globe. The international trade of these drugs and their APIs became a global political issue. Recently Remdesivir injections were in high demand for the treatment. Other than these, many pain, respiratory, sedative, and anesthetic drugs are seeing an exponential rise in demand. The other drugs that are required in curing of miscellaneous infectious diseases experienced subdued demand, as there was low occurrence of such diseases in social distancing environment and through lockdown phases. This trend is envisaged to continue until Covid-19 gets completely eradicated. Hikma ramped up its production to meet the demand for Covid related drugs. It also started manufacturing of Remdesivir. Hikma will continue to see success in launch of Covid-19 related drugs. The remaining section under "Opportunity" is available only in the 'Complete Report' on purchase.

Threat

This section is available only in the 'Complete Report' on purchase.

Major Competitors :

Major Brands :

  • Mitigare
  • ADRIAMYCIN
  • ALLOPURINOL
  • AMIKACIN
  • CISplatin
  • DURAMORPH
  • FLUMAZENIL
  • IDARUBICIN
  • Zortress
  • PROPOFOL
Sample Complete Report
This is the sample complete report which will give you a glimpse of what your complete report will cover after purchase.
Free Summary Report
This report contains the table contents only. In case you need the complete report please purchase using the buy options displayed.
* By clicking on "Buy Now" you agree to accept our "Terms and Conditions."
SWOT & PESTLE (combined)
Complete Report
USD 27
*
  • Debit/Credit card
  • PayPal
Great quality, Affordable pricing.
Safe and secure payments
Hikma Pharmaceuticals plc SWOT and PESTLE Analysis PDF Report is a custom report and will be delivered to your email inbox within 2 business days from purchase.
TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?

You may also be interested in other analyses of Hikma Pharmaceuticals plc:

Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Company Overview Report
This report is shared in order to give you an idea of what the complete Company Overview Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Competitor Analysis Report
This report is shared in order to give you an idea of what the complete Competitor Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Porter's Five Forces Analysis Report
This report is shared in order to give you an idea of what the complete Porter's Five Forces Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
VRIO Analysis Report
This report is shared in order to give you an idea of what the complete VRIO Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Value Chain Analysis Report
This report is shared in order to give you an idea of what the complete Value Chain Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Regulatory Outlook Report
This report is shared in order to give you an idea of what the complete Regulatory Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Risk Analysis Report
This report is shared in order to give you an idea of what the complete Risk Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key Performance Indicators (KPI's) Report
This report is shared in order to give you an idea of what the complete Key Performance Indicators (KPI's) Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Environmental, Social, and Governance (ESG) Analysis Report
This report is shared in order to give you an idea of what the complete Environmental, Social, and Governance (ESG) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
M&A Analysis Report
This report is shared in order to give you an idea of what the complete M&A Report and Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Subsidiaries, Partnerships and Collaborations Report
This report is shared in order to give you an idea of what the complete Subsidiaries, Partnerships and Collaborations Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Stakeholder Analysis Report
This report is shared in order to give you an idea of what the complete Stakeholder Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Technology Landscape and Outlook Report
This report is shared in order to give you an idea of what the complete Technology Landscape and Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Covid-19 Impact Analysis Report
This report is shared in order to give you an idea of what the complete Covid-19 Impact Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key News and Events Report
This report is shared in order to give you an idea of what the complete Key News and Events Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
BCG Analysis Report
This report is shared in order to give you an idea of what the complete BCG Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Digital Marketing and Social Media Strategy Analysis Report
This report is shared in order to give you an idea of what the complete Digital Marketing and Social Media Strategy Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Segmentation, Targeting and Positioning (STP) Analysis Report
This report is shared in order to give you an idea of what the complete Segmentation, Targeting and Positioning (STP) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Ansoff Matrix Analysis Report
This report is shared in order to give you an idea of what the complete Ansoff Matrix Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
No Thanks
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.

Check Out Analysis of Other Relevant Companies

Sartorius AG
Orion Corporation
Lonza Group AG
BioNTech SE
Biocon Limited
Viatris
References used in Hikma Pharmaceuticals plc SWOT & PESTLE Analysis Report

1. Annual Report - https://www.hikma.com/media/3129/hikma_ara_2021_full-interactive.pdf
2. Investors Presentation - https://www.hikma.com/media/3045/generics-mtm-presentation_v21-final.pdf
3. Covid-19 Created an Elective Surgery Backlog. How Can Hospitals Get Back on Track? - https://hbr.org/2020/08/covid-19-created-an-elective-surgery-backlog-how-can-hospitals-get-back-on-track
4. Amarin Files Patent Infringement Lawsuit Against Hikma - https://www.globenewswire.com/news-release/2020/12/01/2137000/0/en/Amarin-Files-Patent-Infringement-Lawsuit-Against-Hikma.html
The detailed complete set of references are available on request in the 'Complete report' on purchase.

How to Reference This Page?

You can use the following in your reference section in order to give credit to the source. For different referencing styles and detailed guidelines, please click here.

Hikma Pharmaceuticals plc SWOT and PESTLE Analysis - SWOT & PESTLE.COM

SWOT & PESTLE.com (2024). Hikma Pharmaceuticals plc SWOT and PESTLE Analysis - SWOT & PESTLE.com. [online] Available at: https://www.swotandpestle.com/hikma-pharmaceuticals/ [Accessed 30 Apr, 2024].

In-text: (SWOT & PESTLE.com, 2024)

Copyrights and Disclaimer

Hikma Pharmaceuticals plc SWOT and PESTLE analysis has been conducted by Mohit Harishchandra Deshmukh and reviewed by senior analysts from Barakaat Consulting.

Copyright of Hikma Pharmaceuticals plc SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions and Disclaimer for usage guidelines.

Hikma Pharmaceuticals plc SWOT and PESTLE Analysis
Price : USD 27
TESTIMONIALS
ORDER A CUSTOM REPORT

Are you looking for a report which is not covered on our website?

Do you want us to design a market survey or write a market research report as per your specific requirements?

Proceed

ADVERTISE WITH US

Reach thousands of academicians and corporates across the globe. With high ASD, your ad post will be displayed across all our 2500+ pages.
Grow your business with effective advertisement!

Proceed

Home About Us Contact Us Login  /  SignUp Privacy Policy Terms and Conditions Disclaimer FAQs Sitemap GO TO TOP
Copyright © 2024. All Rights Reserved by Barakaat Consulting.
➤
Open chat
1
Hello
How can I Help You?